Object-oriented design tools for supramolecular devices and biomedical nanotechnology

Annals of the New York Academy of Sciences

Volumn 1013, Issue , 2004, Pages 110-123

  Lee, Stephen C ^a,b,c   Bhalerao, Khaustaub ^a   Ferrari, Mauro ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c The Ohio State University   (United States)

Author keywords

Nanobiological; Nanobiotechnology; Nanodevice; Nanotechnology; Nanotherapeutic; Object oriented design, OOD; Systems engineering; Therapeutic platform; Unified modeling language, UML

Indexed keywords

VACCINE;

BIOMEDICAL ENGINEERING; CONFERENCE PAPER; MEDICAL INSTRUMENTATION; MEDICAL TECHNOLOGY; MOLECULAR BIOLOGY; NANOTECHNOLOGY; NONHUMAN; SUPRAMOLECULAR CHEMISTRY;

EID: 2942572076     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1305.012     Document Type: Conference Paper

References (34)

1. AGARWAL, S. 2001. CASE tools and UML: state of the ART. Top Health Information Management 21: 38-49.
2. AGGARWAL, V. 2002. The application of the unified modeling language in object-oriented analysis of healthcare information systems. Journal of Medical Systems 26: 383-397.
3. BAKER, J.R., JR. 1998. Therapeutic nanodevices. Biological Molecules in Nanotechnology: The Convergence of Biotechnology, Polymer Chemistry and Materials Science. S.C. Lee & L. Savage, Eds.: 173-183. Southborough, MA: IBC Press.
4. BAKER, J.R., JR., et al. 2001. The synthesis and testing of anti-cancer therapeutic nanodevices. Biomedical Microdevices 3: 61-69.
5. BOOCH, G., J. RUMBAUGH & I. JACOBSON. 1999. The Unified Modeling Language User Guide. Boston: Addison-Wesley.
6. DUNCAN, R. 1997. Drug targeting: where are we now and where are we heading? Journal of Drug Targeting 5: 1-4.
7. DUNCAN, R. 1997. Polymer therapeutics for tumor specific delivery. Chemistry and Industry 7: 262-264.
8. DUNCAN, R., et al. 2001. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. Journal of Controlled Release 74: 135-46.
9. FERNANDEZ-LOPEZ, S., et al. 2001. Antibacterial agents based on the cyclic D,L-α-peptide architecture. Nature 414: 329.
10. GUISEPPI-ELIE, A., C. LEI & R.H. BAUGHMAN. 2002. Direct electron transfer of glucose oxidase on carbon nanotubes. Nanotechnology 13: 559-564.
11. GOLDIN, D.S., et al. 2001. Biomedicine. The NASA-NCI collaboration on biomolecular sensors. Science 292: 443-444.
12. HAHN, G., et al. 2003. Tn7-mediated introduction of DNA sequences into bacmid-cloned cytomegalovirus genomes for rapid recombinant virus construction. Journal of Virological Methods 107: 185-94.
13. HAMOUDA, T., et al. 2001. A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiological Research 156: 1-7.
14. JELINSKI, L. 1997. Biological, carbon and theory issues: overview. WTEC Workshop Report on R&D Status and Trends in Nanostructured Materials and Nanodevices in the United States. R.W. Siegel, E. Hu & M.C. Roco, Eds.: 161-168. Baaltimore, MD: International Technology Research Institute.
15. JELINSKI, L. 1999. Biologically related aspects of nanoparticles, nanostructured materials and nanodevices. Nanostructure Science and Technology. R.W. Siegel, E. Hu & M.C. Roco, Eds.: 113-130. Dordrecht: Kluwer Academic Publishers.
16. LEE, S.C. 1998. Biotechnology for nanotechnology. Trends in Biotechnology 16: 239-240.
17. LEE, S.C. 1998. The nanobiological strategy for construction of nanodevices. Biological Molecules in Nanotechnology: The Convergence of Biotechnology, Polymer Chemistry and Materials Science. S.C. Lee & L. Savage, Eds.: 3-14. Southborough, MA: IBC Press.
18. LEE, S.C. 2001. Dendrimers in nanobiological devices. Dendrimers and Other Dendritic Polymers. D. Tomalia & J. Frechet, Eds.: 548-557. London: John Wiley.
19. LEE, S.C., et al. 1994. Method of producing recombinant viruses in bacteria. U.S. Patent 5,348,886.
20. LOCKMAN, P., et al. 2002. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Development Industry Pharmacology 28: 1-13.
21. LEUSCH, M.S., S.C. LEE & P.O. OLINS. 1995. A novel host-vector system for direct selection of recombinant baculoviruses (bacmids) in Escherichia coli. Gene 160: 191-194.
22. LUCKOW, V.A. 1993. Baculovirus systems for the expression of human gene products. Current Opinions in Biotechnology 4: 564-572.
23. LUCKOW, V.A., et al. 1993. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. Journal of Virology 67: 4566-79.
24. MARQUARDT, W. 1996. Trends in computer-aided process modeling. Computers in Chemical Engineering 20: 591-609.
25. MERKLE, R.C. 1999. Biotechnology as a route to nanotechnology. Trends in Biotechnology 17: 271-274.
26. MI, Z., et al. 2000. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Molecular Therapy 2: 339-347.
27. PROKOP, A. 2001. Bioartificial organs in the twenty-first century: nanobiological devices. Annals of the New York Academy of Sciences 944: 472-490.
28. QUINTANA, A., et al. 2002. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharmaceutical Research 19: 1310-1316.
29. RAYCHANDURI, S. & K.L. ROCK. 1998. Fully mobilizing host defense: building better vaccines. Nature Biotechnology 16: 1025-1031.
30. REUTER, J.D., et al. 1999. Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers. Bio conjugation Chemistry 10: 271-278.
31. RICHARDS, C.A. & M.P. WEINER. 2001. System for generating recombinant viruses. U.S. Patent 6,291,214.
32. SOPPIMATH, K., et al. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release 70: 1-20.
33. WADIA, J.S. & S.F. DOWDY. 2003. Modulation of cellular function by TAT mediated transduction of full length proteins. Current Protein and Peptide Science 4: 97-104.
34. WALHOUT, A.J., et al. 2000. GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods in Enzymology 328: 575-592.